Here’s the thing: I tell some of my younger mentees #SoMe is great but make sure you’re not trapped into that role

I’ve been in practice for 15 years:
🔺Did live transmissions when few women (& men for that matter) were doing them
🔺Led & participated in registries & documents

LIVE from Boston: #HRStv host AFPanico is joined by Kamala Tamirisa MD to discuss Health, Equity, and Inclusion. Highlighting the great work done by HRS to support DEI including the Abstract Awards Session that took place today #EPeeps ➡️ bit.ly/3WRncVr

#HRS2024

🚨1st SHORE pub‼️ > 2k🫀transplants, dual non-invasive rejection surveillance with GEP & dd-cfDNA:
1. ⬆️yield for ACR over either test alone
2. ⬇️number of biopsies
3. Great survival and🫀LVEF
Kiran Khush JHLT The ISHLT American Society of Transplantation (AST) HFSA Nir Uriel, MD MSc
jhltonline.org/article/S1053-…

The TCACC Annual Meeting will be here before you know it! 📣 Be sure to mark your calendars for October 19th and 20th and plan to join TCACC in Irving for a weekend of CME, networking, and more!

#HFBeat Episode Drop 🎧 Michael H. Beasley, MD and Priya Umapathi welcome @nurtitionHF and Adrian da Silva to discuss the evaluation and management of obesity in patients with heart failure. Plus, Michael talks to transplant recipient Mr. Spiro Papakosmas about his experience with heart

This is AL amyloid, as LV function improves over weeks while controlling light chain production with a dara-based regimen, systolic BP goes from 70-80s to 90-100s (reflection of improved cardiac output). Big difference in symptoms and HF
#Amyloidosis

The May issue of Journal of Cardiac Failure is now available online!

▶️ Isovolumic Contraction Velocity in HFrEF
▶️ The Cardiac Amyloidosis Registry Study (CARS)
▶️ Actigraphy in HF Clinical Trials: State-of-the-Art Review

Read more >> onlinejcf.com/current#

Do you love hemodynamics?!

Come join us for the 1st Annual Chicago Hemodynamic Forum!

uchicagohemodynamics.com

Planning pregnancy for #ARVC #AC M #AC arrhythmogenic CM #HeartFailure 2024 #HeartFailure

Calling all critical care clinicians! ‍

Join us for the 5th Annual Advances in Critical Care Symposium, a LIVE 2-day event on October 11-12, 2024 at The Westin Houston Medical Center.

BCM_Surgery St. Luke's Health MD SubhasisChatterjeeMD José L. Díaz-Gómez, MD, MAS, FCCM, FASE, NCC(UCNS)

Register now: texasheart.org/education/cont…

What is a cost-effective GDMT strategy for HFmrEF/HFpEF?

We built a model w/ clinical trial data (TOPCAT, PARAGON-HF, EMPEROR/DELIVER) and simulated outcomes w/ regimens of MRA/SGLT2i/ARNi.

Best 💊 combo?
MRA + SGLT2i

ARNi ⬇️ value at current 💵

Treat HF with urgency!

🔥 of the press in the European Heart Journal: Semaglutide and Diuretic use in obesity-related HFpEF. Large effects of semaglutide on reducing loop diuretic use and dose in the STEP-HFPEF Program
Andrew J Sauer MD
Ankeet S. Bhatt, MD, MBA
Sanjiv J. Shah, MD
Kavita Sharma
Muthu Vaduganathan
academic.oup.com/eurheartj/adva…

A big day for treatment of obstructive #HCM . We now have a second treatment option in the #myosininhibitor class.

Amazing data. Grateful to have contributed and more data are coming!

Aficamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy: nejm.org/doi/full/10.10…

Presented at the HFA meeting and simultaneous publication in @JAMA. In this study of 4 large cohorts (ARIC, MESA, REGARDS, WHI) pooling >23,000 self-reported Black participants, the prevalence of the V142I variant was 3.2%. jamanetwork.com/journals/jama/…

Dr BiykemBozkurt delivered an incredible talk on the 🫀- renal axis at #HeartFailure2024 :

📍 #Albuminuria predicts HF risk➡️Annual screening of #eGFR & #UACR in #Type2DM with/without #CKD
📍 #Finerenone is recommended to ⬇️ CV & kidney failure, prevent HF in #CKD & #DM

🫀Very informative slide about on Acute and worsening HF trials

#HeartFailure2024 European Society of Cardiology Wilfried Mullens Muthu Vaduganathan Andrew J Sauer MD Shelley Zieroth Anju Bhardwaj MD FACC Luisa F. Aguilera Mewton Nathan

Stepwise approach to CE-CT in #ECMO adults involving radiographer/radiologist + #ECLS team to jointly optimize circuit & CE for successful imaging
☢️1️⃣ clinical question & imaging request
☢️2️⃣ decision on contrast delivery & VA #ECMO modification
☢️3️⃣ contrast rate & connection

Our analysis of patients with chronic kidney disease (first report of dialysis pts) who received Impella assisted HRPCI in Protect III CircInterventions #CirculationIntv #MedTwitter #CardioTwitter

💥Lower eGFR had more severely calcified CAD, greater atherectomy usage but no increased

Outstanding new commentary on trial design/differences b/t DAPA-MI & EMPACT-MI on use of SGLT2i post MI in JACC Journals #JACC by Muthu Vaduganathan + Alex Peikert

Can expected early improvements in EF post MI counter the risk of long term worsening HF?

📎: jacc.org/doi/10.1016/j.…

NEW! 2024 AHA/ACC #HCM guidelines out today incorporating cardiac myosin inhibitors and other updates! Happy to be a coauthor with chair Steve Ommen, MD AHA Science American College of Cardiology SCAI Now HCMBeat HCMA - Hypertrophic Cardiomyopathy Association Matthew W Martinez Anju Bhardwaj MD FACC Ankur Kalra David J. Cohen, MD, MSc Anjali Owens Ahmad Masri